[HTML][HTML] Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
…, L Del Sorbo, SL Walmsley, S Belga… - The Lancet …, 2021 - thelancet.com
Background Elevated proinflammatory cytokines are associated with greater COVID-19 severity.
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
Inflammatory bowel disease cause-specific mortality: a primer for clinicians
Background Inflammatory bowel disease (IBD), including Crohn's disease (CD) and
ulcerative colitis (UC) is perceived to harbor significant morbidity but limited excess mortality, …
ulcerative colitis (UC) is perceived to harbor significant morbidity but limited excess mortality, …
Association between frailty and 30-day outcomes after discharge from hospital
S Kahlon, J Pederson, SR Majumdar, S Belga, D Lau… - Cmaj, 2015 - Can Med Assoc
Background: Readmissions after hospital discharge are common and costly, but prediction
models are poor at identifying patients at high risk of readmission. We evaluated the impact of …
models are poor at identifying patients at high risk of readmission. We evaluated the impact of …
Invasive Amoebiasis: A Review of Entamoeba Infections Highlighted with Case Reports
C Skappak, S Akierman, S Belga, K Novak… - Canadian Journal of …, 2014 - hindawi.com
… Les auteurs présentent deux cas : l’un d’une personne qui ne s’était pas rendue dans une
région endémique et l’autre, d’une personne née en Bulgarie. Toutes deux avaient eu des …
région endémique et l’autre, d’une personne née en Bulgarie. Toutes deux avaient eu des …
Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial
… Using Fisher’s exact method with a 15% absolute risk to increase the proportion with resolution
of … For participants with missing survey data, we carried forward their last day’s survey …
of … For participants with missing survey data, we carried forward their last day’s survey …
[HTML][HTML] Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon
S Belga, KE Doucette - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
… Conflict-of-interest statement: Belga S has no conflict of interest to declare; Doucette KE
has received speaker honoraria from Bristol-Myers Squibb and Gilead and has received …
has received speaker honoraria from Bristol-Myers Squibb and Gilead and has received …
[HTML][HTML] European Echinococcus multilocularis Identified in Patients in Canada
…, S Belga, C MacDonald, S Vaughan… - … England Journal of …, 2019 - Mass Medical Soc
… Although parasitic genotyping was not possible in samples obtained from one of the
patients because of poor DNA quality, the patient’s travel history indicated likely local …
patients because of poor DNA quality, the patient’s travel history indicated likely local …
Patient-reported discharge readiness and 30-day risk of readmission or death: a prospective cohort study
…, SR Majumdar, JL Pederson, S Belga, S Kahlon… - The American Journal of …, 2016 - Elsevier
Background Early readmissions to hospital after discharge are common, and clinicians cannot
accurately predict their occurrence. We examined whether patients who feel unready at …
accurately predict their occurrence. We examined whether patients who feel unready at …
[HTML][HTML] Epidemiological and clinical characteristics of alveolar echinococcosis: an emerging infectious disease in Alberta, Canada
S Houston, S Belga, K Buttenschoen… - The American journal …, 2021 - ncbi.nlm.nih.gov
… In most cases, malignancy was initially suspected as the explanation for the liver lesion(s). …
Muller N, Frei E, Nunez S, Gottstein B, 2007. Improved serodiagnosis of alveolar …
Muller N, Frei E, Nunez S, Gottstein B, 2007. Improved serodiagnosis of alveolar …
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series
… Although Patient 3’s presentation was compatible with a hemophagocytic syndrome, the
patient's age and desire to preserve cell-mediated immunity in the setting of disseminated TB …
patient's age and desire to preserve cell-mediated immunity in the setting of disseminated TB …